English

Shockwave Medical, Inc.

EDGAR

SWAV Quarterly report (10-Q) · filed 2024-05-06

32 filing records in this dataset, filed from 2019-02-08 to 2024-05-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

219 million USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 218805000 USD Source

Operating margin

19.38%

2024 Q1 · %

Exact inputs and evidence

Operating Income: 42407000 USD Source
Revenue: 218805000 USD Source

Operating cash flow

35.8 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 35840000 USD Source

Free cash flow

27.5 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 35840000 USD Source
Capital Expenditure: 8389000 USD Source

Cash and cash equivalents: 282 million USD 2024-03-31 Source
Exact value

281674000 USD
Long-term debt including current maturities: 24.3 million USD 2023-06-30 Source
Exact value

24266000 USD
Shares outstanding: 37 million shares 2023-12-31 Source
Exact value

36990700 shares

Reported share-count change

2.08% · 755 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

36235546 shares · 2022-12-31· Source
36990700 shares · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

788 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Revenue: 180165000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 186020000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 730230000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 527251000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 218805000 USD · 2024-01-01 – 2024-03-31 Source

Net income

163 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Net income: 28862000 USD · 2023-04-01 – 2023-06-30 Source
Net income: 34986000 USD · 2023-07-01 – 2023-09-30 Source
Net income: 147278000 USD · 2023-01-01 – 2023-12-31 Source
Net income: 102973000 USD · 2023-01-01 – 2023-09-30 Source
Net income: 55346000 USD · 2024-01-01 – 2024-03-31 Source

Operating cash flow

198 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: 73699000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 33962000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: 124350000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: 73699000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 196053000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: 124350000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: 35840000 USD · 2024-01-01 – 2024-03-31 Source

Capital expenditure

31.8 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Capital expenditure: 15936000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 7188000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 22474000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 15936000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 30595000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 22474000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 8389000 USD · 2024-01-01 – 2024-03-31 Source

Free cash flow

166 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: 73699000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 33962000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: 124350000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: 73699000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: 196053000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: 124350000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: 35840000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 15936000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 7188000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 22474000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 15936000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 30595000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 22474000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 8389000 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-06.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2023-12-31
Operating income: 7 of 11 periods available· newest 2023-12-31
Net income: 7 of 11 periods available· newest 2023-12-31
Operating cash flow: 7 of 11 periods available· newest 2023-12-31
Capital expenditure: 7 of 11 periods available· newest 2023-12-31
Total assets: 7 of 11 periods available· newest 2023-12-31
Total liabilities: 7 of 11 periods available· newest 2023-12-31
Current assets: 7 of 11 periods available· newest 2023-12-31
Current liabilities: 7 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2022-12-31
Shares outstanding: 7 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+49.1%

Prior period

USD 489.73 million

2022-01-01 – 2022-12-31
Current period

USD 730.23 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

730230000 − 489733000 = 240497000 USD

489733000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
730230000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Year-over-year change in Revenue: 240497000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 730230000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2115091 Filing: 000164254524000063 Input fundies:Revenue: 489733000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2116077 Filing: 000164254524000063
The citation records this snapshot. The page link may show a newer release later.
Net income
-31.8%

Prior period

USD 216 million

2022-01-01 – 2022-12-31
Current period

USD 147.28 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

147278000 − 215996000 = -68718000 USD

215996000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
147278000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Year-over-year change in Net income: -68718000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 147278000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2130675 Filing: 000164254524000063 Input fundies:NetIncome: 215996000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2131455 Filing: 000164254524000063
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+66.5%

Prior period

USD 117.73 million

2022-01-01 – 2022-12-31
Current period

USD 196.05 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

196053000 − 117732000 = 78321000 USD

117732000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
196053000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Year-over-year change in Operating cash flow: 78321000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 196053000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390185 Filing: 000164254524000063 Input fundies:OperatingCashFlow: 117732000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390837 Filing: 000164254524000063
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+21.8%

Prior period

USD 25.13 million

2022-01-01 – 2022-12-31
Current period

USD 30.6 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

30595000 − 25126000 = 5469000 USD

25126000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
30595000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Year-over-year change in Capital expenditure: 5469000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 30595000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397044 Filing: 000164254524000063 Input fundies:CapitalExpenditure: 25126000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397639 Filing: 000164254524000063
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 730.23 million 100% of revenue
Operating costs Derived USD 571.14 million 78% of revenue
Operating income USD 159.09 million 22% of revenue
Tax, interest and other Derived USD 11.82 million 1.6% of revenue
Net income USD 147.28 million 20% of revenue

Cash

Operating cash flow USD 196.05 million 27% of revenue
Capital expenditure USD 30.6 million 4.2% of revenue
Free cash flow Derived USD 165.46 million 23% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 1,896% of revenue.
2018 Operating loss: operating costs were 436% of revenue.
2019 Operating loss: operating costs were 221% of revenue.
2020 Operating loss: operating costs were 197% of revenue.
2021 Operating loss: operating costs were 100% of revenue.
2022 Net income was higher than operating income, so the split is not drawn.
2023 20%78%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	1719000	32584000 Derived	-30865000	-250000 Derived	-30615000	-30772000 Derived	Source 2017-01-01 – 2017-12-31: 1719000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -30865000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -30615000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -30347000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 425000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	12263000	53463000 Derived	-41200000	-98000 Derived	-41102000	-43446000 Derived	Source 2018-01-01 – 2018-12-31: 12263000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -41200000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -41102000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -41465000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1981000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	42927000	94766000 Derived	-51839000	-730000 Derived	-51109000	-51924000 Derived	Source 2019-01-01 – 2019-12-31: 42927000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -51839000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -51109000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -48107000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3817000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	67789000	133452000 Derived	-65663000	36000 Derived	-65699000	-82704000 Derived	Source 2020-01-01 – 2020-12-31: 67789000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -65663000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -65699000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -71184000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 11520000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	237146000	238017000 Derived	-871000	8265000 Derived	-9136000	2597000 Derived	Source 2021-01-01 – 2021-12-31: 237146000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -871000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -9136000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 15036000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 12439000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	489733000	365599000 Derived	124134000	-91862000 Derived	215996000	92606000 Derived	Source 2022-01-01 – 2022-12-31: 489733000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 124134000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 215996000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 117732000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 25126000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	730230000	571137000 Derived	159093000	11815000 Derived	147278000	165458000 Derived	Source 2023-01-01 – 2023-12-31: 730230000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 159093000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 147278000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 196053000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 30595000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 730.2M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	1719000	Revenue: 1719000 Open source
20182018-12-31	Revenue	12263000	Revenue: 12263000 Open source
20192019-12-31	Revenue	42927000	Revenue: 42927000 Open source
20202020-12-31	Revenue	67789000	Revenue: 67789000 Open source
20212021-12-31	Revenue	237146000	Revenue: 237146000 Open source
20222022-12-31	Revenue	489733000	Revenue: 489733000 Open source
20232023-12-31	Revenue	730230000	Revenue: 730230000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

49.1% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 1719000 Open source
20182018-12-31	Year over year	613.4%	Revenue: 12263000 Open source Revenue: 1719000 Open source
20192019-12-31	Year over year	250.1%	Revenue: 42927000 Open source Revenue: 12263000 Open source
20202020-12-31	Year over year	57.9%	Revenue: 67789000 Open source Revenue: 42927000 Open source
20212021-12-31	Year over year	249.8%	Revenue: 237146000 Open source Revenue: 67789000 Open source
20222022-12-31	Year over year	106.5%	Revenue: 489733000 Open source Revenue: 237146000 Open source
20232023-12-31	Year over year	49.1%	Revenue: 730230000 Open source Revenue: 489733000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 21.8% 2023

Net margin 20.2% 2023

Free cash flow margin 22.7% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-1,795.5%	Operating Income: -30865000 Open source Revenue: 1719000 Open source
20182018-12-31	Operating margin	-336%	Operating Income: -41200000 Open source Revenue: 12263000 Open source
20192019-12-31	Operating margin	-120.8%	Operating Income: -51839000 Open source Revenue: 42927000 Open source
20202020-12-31	Operating margin	-96.9%	Operating Income: -65663000 Open source Revenue: 67789000 Open source
20212021-12-31	Operating margin	-0.4%	Operating Income: -871000 Open source Revenue: 237146000 Open source
20222022-12-31	Operating margin	25.3%	Operating Income: 124134000 Open source Revenue: 489733000 Open source
20232023-12-31	Operating margin	21.8%	Operating Income: 159093000 Open source Revenue: 730230000 Open source
20172017-12-31	Net margin	-1,781%	Net Income: -30615000 Open source Revenue: 1719000 Open source
20182018-12-31	Net margin	-335.2%	Net Income: -41102000 Open source Revenue: 12263000 Open source
20192019-12-31	Net margin	-119.1%	Net Income: -51109000 Open source Revenue: 42927000 Open source
20202020-12-31	Net margin	-96.9%	Net Income: -65699000 Open source Revenue: 67789000 Open source
20212021-12-31	Net margin	-3.9%	Net Income: -9136000 Open source Revenue: 237146000 Open source
20222022-12-31	Net margin	44.1%	Net Income: 215996000 Open source Revenue: 489733000 Open source
20232023-12-31	Net margin	20.2%	Net Income: 147278000 Open source Revenue: 730230000 Open source
20172017-12-31	Free cash flow margin	-1,790.1%	Revenue: 1719000 Open source Operating Cash Flow: -30347000 Open source Capital Expenditure: 425000 Open source
20182018-12-31	Free cash flow margin	-354.3%	Revenue: 12263000 Open source Operating Cash Flow: -41465000 Open source Capital Expenditure: 1981000 Open source
20192019-12-31	Free cash flow margin	-121%	Revenue: 42927000 Open source Operating Cash Flow: -48107000 Open source Capital Expenditure: 3817000 Open source
20202020-12-31	Free cash flow margin	-122%	Revenue: 67789000 Open source Operating Cash Flow: -71184000 Open source Capital Expenditure: 11520000 Open source
20212021-12-31	Free cash flow margin	1.1%	Revenue: 237146000 Open source Operating Cash Flow: 15036000 Open source Capital Expenditure: 12439000 Open source
20222022-12-31	Free cash flow margin	18.9%	Revenue: 489733000 Open source Operating Cash Flow: 117732000 Open source Capital Expenditure: 25126000 Open source
20232023-12-31	Free cash flow margin	22.7%	Revenue: 730230000 Open source Operating Cash Flow: 196053000 Open source Capital Expenditure: 30595000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 196.1M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-30347000	Operating Cash Flow: -30347000 Open source
20182018-12-31	Operating cash flow	-41465000	Operating Cash Flow: -41465000 Open source
20192019-12-31	Operating cash flow	-48107000	Operating Cash Flow: -48107000 Open source
20202020-12-31	Operating cash flow	-71184000	Operating Cash Flow: -71184000 Open source
20212021-12-31	Operating cash flow	15036000	Operating Cash Flow: 15036000 Open source
20222022-12-31	Operating cash flow	117732000	Operating Cash Flow: 117732000 Open source
20232023-12-31	Operating cash flow	196053000	Operating Cash Flow: 196053000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 165.5M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-30772000	Operating Cash Flow: -30347000 Open source Capital Expenditure: 425000 Open source
20182018-12-31	Free cash flow	-43446000	Operating Cash Flow: -41465000 Open source Capital Expenditure: 1981000 Open source
20192019-12-31	Free cash flow	-51924000	Operating Cash Flow: -48107000 Open source Capital Expenditure: 3817000 Open source
20202020-12-31	Free cash flow	-82704000	Operating Cash Flow: -71184000 Open source Capital Expenditure: 11520000 Open source
20212021-12-31	Free cash flow	2597000	Operating Cash Flow: 15036000 Open source Capital Expenditure: 12439000 Open source
20222022-12-31	Free cash flow	92606000	Operating Cash Flow: 117732000 Open source Capital Expenditure: 25126000 Open source
20232023-12-31	Free cash flow	165458000	Operating Cash Flow: 196053000 Open source Capital Expenditure: 30595000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

57.3% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	8.6%	Total Liabilities: 5127000 Open source Total Assets: 59304000 Open source
20182018-12-31	Liabilities / assets	43.4%	Total Liabilities: 23203000 Open source Total Assets: 53421000 Open source
20192019-12-31	Liabilities / assets	16.9%	Total Liabilities: 39285000 Open source Total Assets: 231938000 Open source
20202020-12-31	Liabilities / assets	17.1%	Total Liabilities: 46388000 Open source Total Assets: 272042000 Open source
20212021-12-31	Liabilities / assets	30%	Total Liabilities: 103852000 Open source Total Assets: 345682000 Open source
20222022-12-31	Liabilities / assets	20.9%	Total Liabilities: 134773000 Open source Total Assets: 646089000 Open source
20232023-12-31	Liabilities / assets	57.3%	Total Liabilities: 897886000 Open source Total Assets: 1566563000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

11.76× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	12.74×	Current Assets: 57859000 Open source Current Liabilities: 4541000 Open source
20182018-12-31	Current assets / current liabilities	5.2×	Current Assets: 48736000 Open source Current Liabilities: 9371000 Open source
20192019-12-31	Current assets / current liabilities	9.03×	Current Assets: 216697000 Open source Current Liabilities: 24008000 Open source
20202020-12-31	Current assets / current liabilities	9.63×	Current Assets: 246300000 Open source Current Liabilities: 25581000 Open source
20212021-12-31	Current assets / current liabilities	5.54×	Current Assets: 285902000 Open source Current Liabilities: 51628000 Open source
20222022-12-31	Current assets / current liabilities	7.25×	Current Assets: 459263000 Open source Current Liabilities: 63374000 Open source
20232023-12-31	Current assets / current liabilities	11.76×	Current Assets: 1225260000 Open source Current Liabilities: 104205000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 30.62 million Exact value Exact value: -30615000 USD 2017-01-01 – 2017-12-31: -30615000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2017-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: -30615000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30615000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459020010523/swav-20191231.xml#161016 Filing: 000156459020010523 The citation records this snapshot. The page link may show a newer release later.	−USD 30.35 million Exact value Exact value: -30347000 USD 2017-01-01 – 2017-12-31: -30347000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2017-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: -30347000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30347000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459020010523/swav-20191231.xml#198205 Filing: 000156459020010523 The citation records this snapshot. The page link may show a newer release later.	USD 425,000 Exact value Exact value: 425000 USD 2017-01-01 – 2017-12-31: 425000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2017-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 425000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 425000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459020010523/swav-20191231.xml#199990 Filing: 000156459020010523 The citation records this snapshot. The page link may show a newer release later.	−USD 30.77 million Calculation and evidence -30347000 − 425000 USD Exact free cash flow: -30772000 USD 2017-01-01 – 2017-12-31: -30347000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 425000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2017-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: -30772000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30347000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459020010523/swav-20191231.xml#198205 Filing: 000156459020010523 Input fundies:CapitalExpenditure: 425000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459020010523/swav-20191231.xml#199990 Filing: 000156459020010523 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 41.1 million Exact value Exact value: -41102000 USD 2018-01-01 – 2018-12-31: -41102000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2018-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: -41102000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41102000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459021009415/swav-20201231.xml#168759 Filing: 000156459021009415 The citation records this snapshot. The page link may show a newer release later.	−USD 41.47 million Exact value Exact value: -41465000 USD 2018-01-01 – 2018-12-31: -41465000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2018-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: -41465000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41465000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459021009415/swav-20201231.xml#209409 Filing: 000156459021009415 The citation records this snapshot. The page link may show a newer release later.	USD 1.98 million Exact value Exact value: 1981000 USD 2018-01-01 – 2018-12-31: 1981000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2018-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 1981000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1981000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459021009415/swav-20201231.xml#211196 Filing: 000156459021009415 The citation records this snapshot. The page link may show a newer release later.	−USD 43.45 million Calculation and evidence -41465000 − 1981000 USD Exact free cash flow: -43446000 USD 2018-01-01 – 2018-12-31: -41465000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1981000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2018-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: -43446000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41465000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459021009415/swav-20201231.xml#209409 Filing: 000156459021009415 Input fundies:CapitalExpenditure: 1981000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459021009415/swav-20201231.xml#211196 Filing: 000156459021009415 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 51.11 million Exact value Exact value: -51109000 USD 2019-01-01 – 2019-12-31: -51109000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2019-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: -51109000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51109000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459022007162/swav-10k_20211231.htm#1863023 Filing: 000156459022007162 The citation records this snapshot. The page link may show a newer release later.	−USD 48.11 million Exact value Exact value: -48107000 USD 2019-01-01 – 2019-12-31: -48107000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2019-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: -48107000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48107000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459022007162/swav-10k_20211231.htm#2513579 Filing: 000156459022007162 The citation records this snapshot. The page link may show a newer release later.	USD 3.82 million Exact value Exact value: 3817000 USD 2019-01-01 – 2019-12-31: 3817000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2019-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 3817000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3817000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459022007162/swav-10k_20211231.htm#2536553 Filing: 000156459022007162 The citation records this snapshot. The page link may show a newer release later.	−USD 51.92 million Calculation and evidence -48107000 − 3817000 USD Exact free cash flow: -51924000 USD 2019-01-01 – 2019-12-31: -48107000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3817000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2019-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: -51924000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48107000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459022007162/swav-10k_20211231.htm#2513579 Filing: 000156459022007162 Input fundies:CapitalExpenditure: 3817000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000156459022007162/swav-10k_20211231.htm#2536553 Filing: 000156459022007162 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 65.7 million Exact value Exact value: -65699000 USD 2020-01-01 – 2020-12-31: -65699000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2020-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: -65699000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65699000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254523000007/swav-20221231.htm#2203478 Filing: 000164254523000007 The citation records this snapshot. The page link may show a newer release later.	−USD 71.18 million Exact value Exact value: -71184000 USD 2020-01-01 – 2020-12-31: -71184000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2020-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: -71184000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -71184000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254523000007/swav-20221231.htm#1385451 Filing: 000164254523000007 The citation records this snapshot. The page link may show a newer release later.	USD 11.52 million Exact value Exact value: 11520000 USD 2020-01-01 – 2020-12-31: 11520000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2020-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 11520000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11520000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254523000007/swav-20221231.htm#1395819 Filing: 000164254523000007 The citation records this snapshot. The page link may show a newer release later.	−USD 82.7 million Calculation and evidence -71184000 − 11520000 USD Exact free cash flow: -82704000 USD 2020-01-01 – 2020-12-31: -71184000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 11520000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2020-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: -82704000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -71184000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254523000007/swav-20221231.htm#1385451 Filing: 000164254523000007 Input fundies:CapitalExpenditure: 11520000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254523000007/swav-20221231.htm#1395819 Filing: 000164254523000007 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 9.14 million Exact value Exact value: -9136000 USD 2021-01-01 – 2021-12-31: -9136000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2021-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: -9136000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9136000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2132236 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 15.04 million Exact value Exact value: 15036000 USD 2021-01-01 – 2021-12-31: 15036000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2021-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: 15036000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15036000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1391489 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 12.44 million Exact value Exact value: 12439000 USD 2021-01-01 – 2021-12-31: 12439000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2021-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 12439000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12439000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1398234 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 2.6 million Calculation and evidence 15036000 − 12439000 USD Exact free cash flow: 2597000 USD 2021-01-01 – 2021-12-31: 15036000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 12439000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2021-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: 2597000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15036000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1391489 Filing: 000164254524000063 Input fundies:CapitalExpenditure: 12439000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1398234 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 216 million Exact value Exact value: 215996000 USD 2022-01-01 – 2022-12-31: 215996000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2022-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: 215996000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 215996000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2131455 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 117.73 million Exact value Exact value: 117732000 USD 2022-01-01 – 2022-12-31: 117732000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2022-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: 117732000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 117732000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390837 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 25.13 million Exact value Exact value: 25126000 USD 2022-01-01 – 2022-12-31: 25126000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2022-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 25126000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25126000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397639 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 92.61 million Calculation and evidence 117732000 − 25126000 USD Exact free cash flow: 92606000 USD 2022-01-01 – 2022-12-31: 117732000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 25126000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2022-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: 92606000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 117732000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390837 Filing: 000164254524000063 Input fundies:CapitalExpenditure: 25126000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397639 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 147.28 million Exact value Exact value: 147278000 USD 2023-01-01 – 2023-12-31: 147278000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Net Income: 147278000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 147278000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#2130675 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 196.05 million Exact value Exact value: 196053000 USD 2023-01-01 – 2023-12-31: 196053000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Operating Cash Flow: 196053000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 196053000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390185 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 30.6 million Exact value Exact value: 30595000 USD 2023-01-01 – 2023-12-31: 30595000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Capital Expenditure: 30595000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30595000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397044 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.	USD 165.46 million Calculation and evidence 196053000 − 30595000 USD Exact free cash flow: 165458000 USD 2023-01-01 – 2023-12-31: 196053000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 30595000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shockwave Medical, Inc. · 2023-12-31 Shockwave Medical, Inc. (edgar:1642545) Free cash flow: 165458000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:46:22Z Snapshot: d3b898ebeac07901a1fee5ad9af219355e2fa70f6a8921292641e21011e2362d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1642545?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 196053000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1390185 Filing: 000164254524000063 Input fundies:CapitalExpenditure: 30595000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000063/swav-20231231.htm#1397044 Filing: 000164254524000063 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 1,914 latest values · 1,914 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001642545, 1642545, SWAV, edgar:1642545

Also known as ShockWave Medical, Inc., Shockwave Medical, Inc.

Shockwave Medical, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation